Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism
Year: 2013
Type: article
Abstract: The controversy around the combined hormonal contraceptives (CHCs) of the so-called third (containing gestodene or desogestrel) and fourth generation (containing drospirenone, DRSP) has reached a h...
Authors: Johannes Bitzer, Jean-Jacques Amy, Rob Beerthuizen, Martin Birkhäuser, Teresa Bombas, Mitchell Creinin, Philip D Darney, Lisa Ferreira Vicente, Kristina Gemzell-Danielsson, Bruno Imthurn, Jeffrey T Jensen, Andrew M Kaunitz, Ali Kubba, Medard M Lech, Diana Mansour, Gabriele Merki, Thomas Rabe, Katarina Sedlecki, David Serfaty, Jacques Seydoux, Lee P Shulman, Regine Sitruk-Ware, Sven O Skouby, Anne Szarewski, James Trussell, Carolyn Westhoff
Institutions: University of Basel, University Hospital of Basel, Menard (Poland)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2016485490